Catalyst Wire Dossier Catalyst Wire Dossier

adjuvanted trivalent influenza vaccine

Influenza vaccine, adjuvanted, trivalent · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for adjuvanted trivalent influenza vaccine, covering 2016-02-03 to 2016-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico. [Phase 3]

See pricing